These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7577590)

  • 21. Efficacy of tacrolimus 0.03% ointment as second-line treatment for children with moderate-to-severe atopic dermatitis: evidence from a randomized, double-blind non-inferiority trial vs. fluticasone 0.005% ointment.
    Doss N; Kamoun MR; Dubertret L; Cambazard F; Remitz A; Lahfa M; de Prost Y
    Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):321-9. PubMed ID: 19563466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluticasone propionate in asthma: a long term dose comparison study.
    Verona E; Petrov D; Cserhati E; Hofman J; Geppe N; Medley H; Hughes S
    Arch Dis Child; 2003 Jun; 88(6):503-9. PubMed ID: 12765916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do topical steroids reduce relapses in adults with atopic dermatitis?
    Williams HC
    Arch Dermatol; 1999 Dec; 135(12):1530-1. PubMed ID: 10606062
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy and safety of combination ointment "fluticasone propionate 0.005% plus mupirocin 2.0%" for the treatment of atopic dermatitis with clinical suspicion of secondary bacterial infection: an open label uncontrolled study.
    Khobragade KJ
    Indian J Dermatol Venereol Leprol; 2005; 71(2):91-5. PubMed ID: 16394380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of PAC-14028 cream - a novel, topical, nonsteroidal, selective TRPV1 antagonist in patients with mild-to-moderate atopic dermatitis: a phase IIb randomized trial.
    Lee YW; Won CH; Jung K; Nam HJ; Choi G; Park YH; Park M; Kim B
    Br J Dermatol; 2019 May; 180(5):1030-1038. PubMed ID: 30623408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two randomized, double-blind, placebo-controlled studies of fluticasone propionate lotion 0.05% for the treatment of atopic dermatitis in subjects from 3 months of age.
    Eichenfield LF; Miller BH;
    J Am Acad Dermatol; 2006 Apr; 54(4):715-7. PubMed ID: 16546598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Addition of topical pimecrolimus to once-daily mid-potent steroid confers no short-term therapeutic benefit in the treatment of severe atopic dermatitis; a randomized controlled trial.
    Spergel JM; Boguniewicz M; Paller AS; Hebert AA; Gallagher PR; McCormick C; Parneix-Spake A; Hultsch T
    Br J Dermatol; 2007 Aug; 157(2):378-81. PubMed ID: 17573885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, open-label study to evaluate an intermittent dosing regimen of fluticasone propionate 0.05% cream in combination with regular emollient skin care in reducing the risk of relapse in pediatric patients with stabilized atopic dermatitis.
    Liu L; Ong G
    J Dermatolog Treat; 2018 Aug; 29(5):501-509. PubMed ID: 29164960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of fluticasone propionate 0.005% ointment in the treatment of psoriasis.
    Olsen EA
    Cutis; 1996 Feb; 57(2 Suppl):57-61. PubMed ID: 8646872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An open-label study of the safety and efficacy of limited application of fluticasone propionate ointment, 0.005%, in patients with atopic dermatitis of the face and intertriginous areas.
    Tan MH; Meador SL; Singer G; Lebwohl MG
    Int J Dermatol; 2002 Nov; 41(11):804-9. PubMed ID: 12453011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients.
    Dransfield MT; Feldman G; Korenblat P; LaForce CF; Locantore N; Pistolesi M; Watkins ML; Crim C; Martinez FJ
    Respir Med; 2014 Aug; 108(8):1171-9. PubMed ID: 24998880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: a three-center, assessor blinded trial.
    Licari A; Ruffinazzi G; DE Filippo M; Castagnoli R; Marseglia A; Agostinis F; Puviani M; Milani M; Marseglia GL
    Minerva Pediatr; 2017 Dec; 69(6):470-475. PubMed ID: 29181960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clobetasol propionate emollient 0.05% in the treatment of atopic dermatitis.
    Maloney JM; Morman MR; Stewart DM; Tharp MD; Brown JJ; Rajagopalan R
    Int J Dermatol; 1998 Feb; 37(2):142-4. PubMed ID: 9542676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
    Medley H; Orozco S; Allen A
    Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of atopic dermatitis.
    Peppers J; Paller AS; Maeda-Chubachi T; Wu S; Robbins K; Gallagher K; Kraus JE
    J Am Acad Dermatol; 2019 Jan; 80(1):89-98.e3. PubMed ID: 30554600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of fluticasone propionate ointment, 0.005%, and hydrocortisone-17-butyrate ointment, 0.1%, in the treatment of psoriasis.
    Nurnberger FG
    Cutis; 1996 Feb; 57(2 Suppl):39-44. PubMed ID: 8646868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study.
    Peserico A; Städtler G; Sebastian M; Fernandez RS; Vick K; Bieber T
    Br J Dermatol; 2008 Apr; 158(4):801-7. PubMed ID: 18284403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double-blind comparison of intranasal fluticasone propionate, 200 micrograms, once daily with 200 micrograms twice daily in the treatment of patients with severe seasonal allergic rhinitis to ragweed.
    Dolovich J; O'Connor M; Stepner N; Smith A; Sharma RK
    Ann Allergy; 1994 May; 72(5):435-40. PubMed ID: 8179230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential effects of fluticasone propionate on bone mineral density in patients with asthma: a 2-year randomized, double-blind, placebo-controlled trial.
    Kemp JP; Osur S; Shrewsbury SB; Herje NE; Duke SP; Harding SM; Faulkner K; Crim CC
    Mayo Clin Proc; 2004 Apr; 79(4):458-66. PubMed ID: 15065610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.